2023 was a tricky yr for your biopharma field, with various businesses downsizing and restructuring their workforces to stay afloat. There are indications of Restoration, as mergers and acquisitions picked up over the pharmaceutical and lifetime sciences field in the latter part of 2023 and possess continued their upswing into https://sites.google.com/view/bio-sites/blog